Why I think $MBOT is the most undervalued, overlooked, multi-bagger around.
Microbot Medical is undervalued due to FDA clearance of its LIBERTY endovascular robotic system, early hospital adoption, and clear 2026 commercialization catalysts including full market release and geographic expansion. Clinical data shows strong efficacy (100% robotic navigation success, 92% radiation exposure reduction), and the company targets a 2.5 million annual procedure market with secured manufacturing capital and growing investor visibility.